Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEC of Lidocaine for AVF Creation
NCT05063578Unknown
- Sponsor
- Far Eastern Memorial Hospital
- Start
- Sep 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lidocaine in end stage renal disease (ESRD), sponsored by Far Eastern Memorial Hospital. Primary endpoint: Minimal effective concentration of lidocaine solution. Status: unknown.
02
Drugs
lidocaine
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT05063578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05063578.